For a non-inferiority test on an absolute risk difference:

Control response rate: pC=0.70p_C = 0.70

Assumed true new treatment rate (for powering NI): pT=0.70p_T = 0.70

NI margin: Δ=0.10\Delta = 0.10 (i.e., rule out pT−pC≤−0.10p_T - p_C \le -0.10)

One-sided α=0.025⇒z1−α≈1.96\alpha = 0.025 \Rightarrow z_{1-\alpha} \approx 1.96

Power =90%⇒z1−β≈1.2816= 90\% \Rightarrow z_{1-\beta} \approx 1.2816

Using the usual large-sample (Wald) planning formula for equal allocation:
n  =  (z1−α+z1−β)2[pT(1−pT)+pC(1−pC)]((pT−pC)−(−Δ))2n \;=\; \frac{\left(z_{1-\alpha}+z_{1-\beta}\right)^2 \left[p_T(1-p_T)+p_C(1-p_C)\right]}{\left((p_T-p_C) - (-\Delta)\right)^2}
Here, (pT−pC)−(−Δ)=0−(−0.10)=0.10(p_T-p_C) - (-\Delta)=0 - (-0.10)=0.10, and
p(1−p)=0.7⋅0.3=0.21p(1-p)=0.7\cdot0.3=0.21, so the variance term is 0.21+0.21=0.420.21+0.21=0.42.
n≈(1.96+1.2816)2⋅0.420.102=(3.2416)2⋅0.420.01≈10.512⋅0.420.01≈441.5n \approx \frac{(1.96+1.2816)^2 \cdot 0.42}{0.10^2}
= \frac{(3.2416)^2 \cdot 0.42}{0.01}
\approx \frac{10.512 \cdot 0.42}{0.01}
\approx 441.5
Answer: 442 patients per group\boxed{442 \text{ patients per group}} (≈ 884 total), before any inflation for dropout/non-evaluable patients.

Quick note on your “detect 60% or lower” line
In a non-inferiority trial, you usually power for success under a plausible true rate (here, 70% vs 70%). If instead you literally want 90% power to detect that the new treatment is 10% worse (i.e., 0.600.60 vs 0.700.70) with one-sided α=0.025\alpha=0.025, the same style formula gives a slightly bigger number:

variance term =0.6(0.4)+0.7(0.3)=0.24+0.21=0.45=0.6(0.4)+0.7(0.3)=0.24+0.21=0.45

n≈(3.2416)2⋅0.450.01≈473n \approx \frac{(3.2416)^2 \cdot 0.45}{0.01} \approx 473
That’s ~473 per group.
If you tell me whether you’ll analyze by risk difference, risk ratio, or odds ratio, and whether you want a Farrington–Manning (common in NI for proportions) vs simple Wald calculation, I can give the matching (often slightly different) sample size.